DK137924C - Fremgangsmaade til fremstilling af 1,4-dihydroquinoliner - Google Patents
Fremgangsmaade til fremstilling af 1,4-dihydroquinolinerInfo
- Publication number
- DK137924C DK137924C DK111074A DK111074A DK137924C DK 137924 C DK137924 C DK 137924C DK 111074 A DK111074 A DK 111074A DK 111074 A DK111074 A DK 111074A DK 137924 C DK137924 C DK 137924C
- Authority
- DK
- Denmark
- Prior art keywords
- dihydroquinolines
- procedure
- preparation
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/10—Spiro-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D215/14—Radicals substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/18—Halogen atoms or nitro radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D219/00—Heterocyclic compounds containing acridine or hydrogenated acridine ring systems
- C07D219/04—Heterocyclic compounds containing acridine or hydrogenated acridine ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
- C07D219/06—Oxygen atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Quinoline Compounds (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19732310746 DE2310746A1 (de) | 1973-03-03 | 1973-03-03 | Verfahren zur herstellung von neuen 1,4-dihydrochinolinen sowie ihre verwendung als arzneimittel |
Publications (2)
Publication Number | Publication Date |
---|---|
DK137924B DK137924B (da) | 1978-06-05 |
DK137924C true DK137924C (da) | 1978-10-30 |
Family
ID=5873779
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK111074A DK137924C (da) | 1973-03-03 | 1974-03-01 | Fremgangsmaade til fremstilling af 1,4-dihydroquinoliner |
Country Status (21)
Country | Link |
---|---|
US (1) | US3910917A (ja) |
JP (1) | JPS49134685A (ja) |
AT (1) | AT328452B (ja) |
AU (1) | AU473590B2 (ja) |
BE (1) | BE811688A (ja) |
CA (1) | CA1024517A (ja) |
CH (1) | CH597191A5 (ja) |
DD (1) | DD113002A5 (ja) |
DE (1) | DE2310746A1 (ja) |
DK (1) | DK137924C (ja) |
ES (1) | ES423716A1 (ja) |
FR (1) | FR2219786B1 (ja) |
GB (1) | GB1421305A (ja) |
HU (1) | HU167415B (ja) |
IE (1) | IE39049B1 (ja) |
IL (1) | IL44329A (ja) |
LU (1) | LU69530A1 (ja) |
NL (1) | NL7402750A (ja) |
PL (1) | PL88760B1 (ja) |
SE (1) | SE403285B (ja) |
ZA (1) | ZA741353B (ja) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6210087A (ja) * | 1985-07-03 | 1987-01-19 | Shionogi & Co Ltd | 4,7−ジヒドロチエノ〔2,3−b〕ピリジン誘導体,その製造法および循環器系疾患治療剤 |
FR2801310B1 (fr) * | 1999-11-24 | 2004-04-16 | Adir | NOUVEAUX DERIVES DE DIHYDROFURO-[3,4-b]QUINOLEIN-1-ONES, LEUR PROCEDE DE PREPARATION ET LES COMPOSITIONS PHARMACEUTIQUES QUI LES CONTIENNENT |
US20110039289A1 (en) * | 2008-03-14 | 2011-02-17 | Pierre Graves | Fluorogenic peptides and their method of production |
US11511900B2 (en) | 2021-03-18 | 2022-11-29 | Osgood Industries, Llc | Adjustable frame mount for process unit |
-
1973
- 1973-03-03 DE DE19732310746 patent/DE2310746A1/de active Pending
-
1974
- 1974-02-25 US US445167A patent/US3910917A/en not_active Expired - Lifetime
- 1974-02-25 AU AU65973/74A patent/AU473590B2/en not_active Expired
- 1974-02-26 CA CA193,511A patent/CA1024517A/en not_active Expired
- 1974-02-27 DD DD176835A patent/DD113002A5/xx unknown
- 1974-02-28 JP JP49022938A patent/JPS49134685A/ja active Pending
- 1974-02-28 HU HU72BA3038A patent/HU167415B/hu unknown
- 1974-02-28 ES ES423716A patent/ES423716A1/es not_active Expired
- 1974-02-28 NL NL7402750A patent/NL7402750A/xx not_active Application Discontinuation
- 1974-02-28 BE BE141484A patent/BE811688A/xx unknown
- 1974-03-01 DK DK111074A patent/DK137924C/da active
- 1974-03-01 IE IE00432/74A patent/IE39049B1/xx unknown
- 1974-03-01 GB GB934074A patent/GB1421305A/en not_active Expired
- 1974-03-01 FR FR7407036A patent/FR2219786B1/fr not_active Expired
- 1974-03-01 SE SE7402771A patent/SE403285B/xx unknown
- 1974-03-01 ZA ZA00741353A patent/ZA741353B/xx unknown
- 1974-03-01 LU LU69530A patent/LU69530A1/xx unknown
- 1974-03-01 CH CH293974A patent/CH597191A5/xx not_active IP Right Cessation
- 1974-03-01 IL IL44329A patent/IL44329A/en unknown
- 1974-03-02 PL PL1974169240A patent/PL88760B1/pl unknown
- 1974-03-04 AT AT173474A patent/AT328452B/de not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
DK137924B (da) | 1978-06-05 |
ATA173474A (de) | 1975-06-15 |
AU6597374A (en) | 1975-08-28 |
CA1024517A (en) | 1978-01-17 |
AT328452B (de) | 1976-03-25 |
CH597191A5 (ja) | 1978-03-31 |
IE39049L (en) | 1974-09-03 |
FR2219786A1 (ja) | 1974-09-27 |
HU167415B (en) | 1976-04-28 |
JPS49134685A (ja) | 1974-12-25 |
AU473590B2 (en) | 1976-06-24 |
PL88760B1 (ja) | 1976-09-30 |
DE2310746A1 (de) | 1974-09-12 |
IL44329A (en) | 1977-08-31 |
BE811688A (fr) | 1974-08-28 |
SE403285B (sv) | 1978-08-07 |
LU69530A1 (ja) | 1974-10-09 |
ES423716A1 (es) | 1976-04-01 |
DD113002A5 (ja) | 1975-05-12 |
FR2219786B1 (ja) | 1977-11-10 |
IL44329A0 (en) | 1974-06-30 |
IE39049B1 (en) | 1978-07-19 |
GB1421305A (en) | 1976-01-14 |
US3910917A (en) | 1975-10-07 |
ZA741353B (en) | 1975-01-29 |
NL7402750A (ja) | 1974-09-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SE7710600L (sv) | Forfarande for framstellning av 1,3-bensoxazoler | |
DK139678B (da) | Fremgangsmåde til fremstilling af 2,2,6,6-tetramethyl-4-oxopiperidin. | |
DK133051C (da) | Analogifremgangsmade til fremstilling af 1,3-oxygenerede 8alfa-ostratriener | |
DK132707C (da) | Analogifremgangsmade til fremstilling af 1,3,16,17-tetraoxygenerede 8alfa-ostratriener | |
DK140406B (da) | Fremgangsmåde til fremstilling af 2,2,6,6-tetramethyl-4-oxopiperidin. | |
DK133050C (da) | Analogifremgangsmade til fremstilling af 3,17,18-trihydroxy-1,3,5(10)-ostratriener | |
DK137389B (da) | Analogifremgangsmåde til fremstilling af 11beta-substituerede delta4-østrener. | |
DK132795C (da) | Fremgangsmade til fremstilling af 2,4-diamino-5-benzylpyrimidiner | |
SE401835B (sv) | Forfarande for framstellning av 17beta-hydroxi-16,16-dimetylest-4-en-3-on | |
DK131855C (da) | Fremgangsmade til fremstilling af 3,4-dihydropyridoner | |
DK137924C (da) | Fremgangsmaade til fremstilling af 1,4-dihydroquinoliner | |
DK132329C (da) | Fremgangsmade til fremstilling af cardenolid-3,alfa-(2'-desoxy-glycosider) | |
DK132221C (da) | Fremgangsmade til fremstilling af 2,4-diamino-5-benzylpyrimidiner | |
DK138895B (da) | Fremgangsmåde til fremstilling af 8-beta-(2'-pyrimidino-aminometyl)-ergolinderivater. | |
DK136619B (da) | Fremgangsmåde til fremstilling af dihydrokanadensolid. | |
DK136183C (da) | Fremgangsmade til fremstilling af 1-chlor-2,2,2-trifluorethyl-difluormethylether | |
DK348575A (da) | Fremgangsmade til fremstilling af 9,11,15-trihydroxy-13,14-dehydro-prostaglandiner | |
DK138946B (da) | Fremgangsmaade til fremstilling af 4-oxa-5-hydroxy-polycycloalkenon-(3)-er. | |
DK132703C (da) | Fremgangsmade til fremstilling af 2,4-diamino-5-benzylpyrimidiner | |
DK352975A (da) | Fremgangsmade til fremstilling af 3beta-(4-oxoalfa-l-rhamnosyl)-14beta-hydroxy-bufa-4,20,22-trienolid | |
DK136603B (da) | Fremgangsmåde til fremstilling af 1alfa-hydroxycholecalciferol. | |
DK134240B (da) | Fremgangsmåde til fremstilling af bicyclomycin. | |
NO138146C (no) | Fremgangsmaate for fremstilling av 2,2`-anhydro-1beta-d-arabinfuranosyl-5-cytosin | |
DK131859C (da) | Fremgangsmade til fremstilling af 2,4-diamino-5-benzylpyrimidiner | |
DK137087B (da) | Fremgangsmåde til fremstilling af 3-keto-6-azido-4,6-bisdehydro-eller -1,4,6-trisdehydro-steroider. |